Ahead of the next chapter in the ongoing UK proceedings regarding the ”Emotional Perception” patent application (application number GB1904713.3), our experts re-cap the story so far and share hopes on what might happen next.
Read more
Following the Supreme Court’s decision in SkyKick v Sky — on 27 June 2025, the UK IPO issued important guidance on how it will now approach trade mark applications — and it’s a significant shift. This article summarises what the new guidance means for trade mark applicants and businesses.
Read more
Last week, the High Court issued its judgment on interim FRAND licences in Samsung v ZTE.
Read more
Discover what it takes to secure protection for AI-driven technologies through real-world scenarios—including autonomy stacks in self-driving vehicles and a computer vision system.
Read more
The Enlarged Board of Appeal issued their decision in the case of G1/24 on 18 June 2025. Our experts discuss the relevance for IP professionals.
Read more
This article examines the legal principles of trade mark exhaustion and explores how brand owners can manage their reputation after goods have been sold.
Read more
In March 2025, the first Cambridge Human Organoid Symposium took place at Jesus College, Cambridge. Having attended, trainee patent attorney Oliver Herd shares the latest research findings presented.
Read more
Recent patent and clinical trial activity highlights a rising global interest in molecular glue research to improve patient outcomes for cancer, neurodegenerative, and autoimmune disease treatments.
Read more
This article explores a major shift in global patent filings for neurodegenerative disorder therapies over the past decade. Once dominated by big pharma’s small molecules, innovation is now increasingly led by SMEs developing biotherapeutics targeting root causes. This trend reflects rising interest in precision medicine and suggests progress toward more effective treatments beyond symptom management.
Read more
In this episode, join Partner and Patent Attorney, Adam Tindall along with Senior Associate and Patent Attorney, Matthew Bennett, as they discuss the current state of IP in the nuclear industry, interesting technology insights, and fusion and fission IP, as featured in their article as part of the Inside Green Innovation: Progress Report.
Read more
In a judgment that further swings the pendulum back towards the UK being a 'SEP-owner-friendly' jurisdiction, the CoA has set the terms of the FRAND licence payable by Apple at a little over $700m ($500m + $200m interest).
Read more
